By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.
The Voice of People With Breast Cancer
Education
Educational Events
Q&E Sessions: A Medical Oncologist Answers Your Questions About HR+ Breast Cancer
A breast cancer diagnosis comes with so many questions and there never seems to be enough time at appointments to have some of these questions answered. To help address this, the Canadian Breast Cancer Network hosts regular Q&E: Questions and Experts sessions. In this series, a variety of experts, including oncologists, genetic counsellors, social workers, and many more, will spend the entire virtual session answering your questions on various topics.
In this Q&E session, Dr. Omar Khan answers your questions about HR+ breast cancer. He will address your concerns and help you better understand HR+ breast cancer, treatment options, and emerging research.
Send your questions on HR+ breast cancer to Rebecca at rarmstrong@cbcn.ca.
Expert Speaker:
Dr. Omar Khan, MD, MBA, FRCPC is a clinical assistant professor at the Cumming School of Medicine and medical oncologist at the Arthur J.E. Child Comprehensive Cancer Centre. He completed his Medical Doctorate at the University of Calgary in 2013, followed by Internal Medicine and Medical Oncology residency training at the University of Calgary from 2013 – 2018. He completed a fellowship in Breast Cancer and Health Administration from 2018 – 2019. He also completed an executive MBA degree at the Ivey Business School at the University of Western Ontario, graduating in 2020. His current clinical practice includes the breast cancer and sarcoma tumour groups. His research interests are in the application of artificial intelligence to clinical cancer care, including projects focusing on imaging biomarkers to predict prognosis in several tumour types (including lung, prostate, breast, colorectal and hepatocellular carcinomas).
When:
Where:
Who:
Key Topic(s):
June 27, 2025 at 2:00PM ET
ONLINE
- Breast cancer patients
- Their families and caregivers
- Your questions about HR+ breast cancer
To register click here.
SHARE
Our Stories
Events
Receive updates by email Subscribe Now
About CBCN
CBCN strives to voice the views and concerns of breast cancer patients through education, advocacy activities, and the promotion of information sharing.
Canadian Breast Cancer Network
185 Somerset St. West Suite 318, Ottawa, ON Canada K2P 0J2
Tel: 613-230-3044
Toll-free: 1-800-685-8820
Email Us
